Berodual HFA-MDI

DEVICE2 trials

Sponsors

Boehringer Ingelheim

Conditions

AsthmaPulmonary Disease, Chronic Obstructive

Phase 4

Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT00153075

Boehringer IngelheimAsthma, Pulmonary Disease, Chronic Obstructive

Start: 2005-09-26End: 2005-12-07Target: 19Updated: 2023-11-29

Evaluation of the Respimat Inhaler vs. a HFA MDI Using Berodual in Patients With COPD With Poor MDI Technique.

CompletedNCT00267917

Boehringer IngelheimAsthma, Pulmonary Disease, Chronic Obstructive

Start: 2006-01-17End: 2006-02-27Target: 13Updated: 2023-12-14